Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN359859 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Fibroblast Growth Factor Receptor 4 (FGFR4) (N-Term) antibody
- Antibody type
- Polyclonal
- Antigen
- This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected from the N-terminal region of human FGFR4.
- Description
- Protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- N-Term
- Vial size
- 0.4 mL
- Concentration
- 0.25 mg/mL
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at-20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references G388R mutation of the FGFR4 gene is not relevant to breast cancer prognosis.
Cytoplasmic expression of fibroblast growth factor receptor-4 in human pituitary adenomas: relation to tumor type, size, proliferation, and invasiveness.
Pituitary tumor AP-2alpha recognizes a cryptic promoter in intron 4 of fibroblast growth factor receptor 4.
The fibroblast growth factor receptor gene Arg388 allele is not associated with early lymph node metastasis of breast cancer.
Immunolocalization of fibroblast growth factor receptors in normal and wounded human skin.
Jézéquel P, Campion L, Joalland MP, Millour M, Dravet F, Classe JM, Delecroix V, Deporte R, Fumoleau P, Ricolleau G
British journal of cancer 2004 Jan 12;90(1):189-93
British journal of cancer 2004 Jan 12;90(1):189-93
Cytoplasmic expression of fibroblast growth factor receptor-4 in human pituitary adenomas: relation to tumor type, size, proliferation, and invasiveness.
Qian ZR, Sano T, Asa SL, Yamada S, Horiguchi H, Tashiro T, Li CC, Hirokawa M, Kovacs K, Ezzat S
The Journal of clinical endocrinology and metabolism 2004 Apr;89(4):1904-11
The Journal of clinical endocrinology and metabolism 2004 Apr;89(4):1904-11
Pituitary tumor AP-2alpha recognizes a cryptic promoter in intron 4 of fibroblast growth factor receptor 4.
Yu S, Asa SL, Weigel RJ, Ezzat S
The Journal of biological chemistry 2003 May 30;278(22):19597-602
The Journal of biological chemistry 2003 May 30;278(22):19597-602
The fibroblast growth factor receptor gene Arg388 allele is not associated with early lymph node metastasis of breast cancer.
Becker N, Nieters A, Chang-Claude J
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003 Jun;12(6):582-3
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003 Jun;12(6):582-3
Immunolocalization of fibroblast growth factor receptors in normal and wounded human skin.
Takenaka H, Yasuno H, Kishimoto S
Archives of dermatological research 2002 Oct;294(7):331-8
Archives of dermatological research 2002 Oct;294(7):331-8
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- Western blot analysis of anti-FGFR4 Pab in THP-1 cell lysate. FGRFR4 (Arrow) was detected using purified Pab. Secondary HRP-anti-rabbit was used for signal visualization with chemiluminescence.
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary antibody, which was peroxidase-conjugated to the secondary antibody, followed by AEC staining.